WO1996019187A1 - Agent stimulant la croissance capillaire - Google Patents
Agent stimulant la croissance capillaire Download PDFInfo
- Publication number
- WO1996019187A1 WO1996019187A1 PCT/RU1994/000287 RU9400287W WO9619187A1 WO 1996019187 A1 WO1996019187 A1 WO 1996019187A1 RU 9400287 W RU9400287 W RU 9400287W WO 9619187 A1 WO9619187 A1 WO 9619187A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair growth
- agent
- growth
- stimulating hair
- stimulating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
Definitions
- the invention is available in medicine and in medicine, may be used to treat baldness (alopecia), to strengthen hair loss and stimulate the treatment of gastric pain.
- This product improves microcirculation, stimulates the transfer of the cells of the active cell.
- the product is oxidized, which is used externally in the form of gels, ointments, lotion, or solution, which shows the greatest effect of small incidence,
- minoxid should follow the duration of treatment. The effect is observed no earlier than 4 months after the start of treatment. After a change of the drug, after 3-4 months the effect of treatment may disappear. Otherwise, the drug has significant indications: lactation, pregnancy, heart treatment, the use of hypotensive drugs. (The reference is “Drugs abroad for foreign companies in Russia, 1993, Moscow,“ Health insurance ”p. 388-389).
- a drug is known for the treatment of baldness.
- This product is manufactured in a wide range of industrialized areas. ( ⁇ . ⁇ réelle ⁇ , ⁇ . ⁇ - technically ⁇ , ⁇ . ⁇ . ⁇ participat ⁇ réelle ⁇ réelle ⁇ . ⁇ réelle ⁇ ⁇ ⁇ ⁇ Conduct ⁇ réelle ⁇ 5 ⁇ - ⁇ DD
- ⁇ . ⁇ The dysklosporin accelerates the growth of Volos.
- this product also has a wide list of indications. This is due to the fact that the cyclosphere exhibits a pronounced immune-mediated effect and is a strong immune modulator.
- a commercial composition for accelerating the growth of vol- ume containing glycopyrotein is known.
- the main component of this product in the form of 25 lotions for fluids is available as a basic substance, although there is a lot of mixes available for free. ⁇ It may also be possible to have added a good acid to enhance microcirculation and / or heparin or hepatic sulphate. zo (See application ⁇ C ⁇ -Che ⁇ 90/09 778, cl. ⁇ 61 ⁇ 7 / 06, ⁇ .1990)
- the main disadvantage of this system is: weakly expressed form factor and high cost of the drug.
- the closest to the proposed invention is the means to prevent the loss of hair and stimulate them
- Acids derived from natural vegetable oil and containing 80% of linoleic acid, its salt and / or linoleic acid are derived from natural vegetable oil and containing 80% of linoleic acid, its salt and / or linoleic acid.
- the main disadvantage of the above described equipment is the lack of an expressed form factor for a long time, in particular 3-4 months.
- the main objective of the invention is to build a device to stimulate the growth of the hair, which is characterized by a high incidence of the disease, and the fact that the The task posed is resolved by means for stimulating the growth of the environment on the main body of acid, which provides a mixture of acid and saline:
- the proposed medicament for stimulating the growth of the environment was used on animals in the laboratory and on patients.
- the possible implementation of the invention is illustrated by the following specific examples.
- the unit is evaporated in a vacuum, the unit is removed from ethanol. The dedicated plant is dried.
- Example 2 (Production of Valeria) - a lotus. Hazardous acid (water) When mixed and cooled, it adds an equivalent amount of water to the product. Further, the device is evaporated in a vacuum, the installation is uninstalled.
- Example 3 (Production of Ca ⁇ inata) - ointment. In addition to a mixture of acid (30%), when added, it adds a half of the CaC1 environmentally friendly solution 2 . The mixture obtained is heated and added equal to the quantity of ethyl alcohol. The filtering plant is filtered and dried in a vacuum. Essential quantities of material are introduced into the ointment base, with active mixing. When mixed, add preservative and scent.
- Example 4. (Use of the butyrate on live). Butropium is apertured and sold in experiments on laboratory live animals. ⁇ ysys males, weight 1 10-150 g ⁇ amm. In blue, with scissors, we won a Baltic outburst at an area of 4 cm.
- the preparation was applied in 0.5 grams of ointment base and rubbed the ointment into the skin. The procedure was carried out daily for 18 days. ⁇ For 6 days, on an otherwise well-known group of live animals, active growing waves were observed. ⁇ 8-12 days ago, the Easter cake was restored and became convenient to the skin. The live group, on top of that, they applied the ointment base without the preparation, but the end of the period of the invasion of the United Kingdom was not a part of the Great Territory.
- the patient is 24 years old, the diagnosis is alopecia areata.
- Two overexposed sections of the head inflicted an ointment base containing 6 m of bombardment.
- Business was done twice a day.
- One deprived part of the head treated the ointment base without a preparation.
- the effect of the drug was seen at 6 _ -
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne la médecine ainsi que les cosmétiques et peut être utilisée dans le traitement de la calvitie (alopécie) ainsi que pour renforcer les cheveux et stimuler la croissance capillaire. L'invention par essence est un agent de stimulation de la croissance capillaire à base d'un mélange d'acides carboxyliques de la formule générale (I) dans laquelle R représente C2H5, C3H7, C4H9, et X représente Me+, Me++.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU1994/000287 WO1996019187A1 (fr) | 1994-12-22 | 1994-12-22 | Agent stimulant la croissance capillaire |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU1994/000287 WO1996019187A1 (fr) | 1994-12-22 | 1994-12-22 | Agent stimulant la croissance capillaire |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996019187A1 true WO1996019187A1 (fr) | 1996-06-27 |
Family
ID=20129895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU1994/000287 WO1996019187A1 (fr) | 1994-12-22 | 1994-12-22 | Agent stimulant la croissance capillaire |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1996019187A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017273A1 (fr) * | 1996-10-25 | 1998-04-30 | Ansan Pharmaceuticals, Inc. | Procedes mettant en oeuvre un acide butyrique ou des derives d'acide butyrique pour prevenir la perte de cheveux |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2374027A1 (fr) * | 1976-12-20 | 1978-07-13 | Henkel Kgaa | Utilisation d'esters alcoxymethyliques d'acides carboxyliques pour l'amelioration de la structure de chevelures endommagees |
DE3430166A1 (de) * | 1983-11-30 | 1985-06-05 | Akiyoshi Yao Osaka Kitano | Shampoo zur verhinderung von haarausfall und zur foerderung von haarwuchs |
FR2620330A1 (fr) * | 1987-09-15 | 1989-03-17 | Fabre Pierre Cosmetique | Composition anti-alopecique comportant du minoxidil |
-
1994
- 1994-12-22 WO PCT/RU1994/000287 patent/WO1996019187A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2374027A1 (fr) * | 1976-12-20 | 1978-07-13 | Henkel Kgaa | Utilisation d'esters alcoxymethyliques d'acides carboxyliques pour l'amelioration de la structure de chevelures endommagees |
GB1576165A (en) * | 1976-12-20 | 1980-10-01 | Henkel Kgaa | Hair structure composition and method using same |
DE3430166A1 (de) * | 1983-11-30 | 1985-06-05 | Akiyoshi Yao Osaka Kitano | Shampoo zur verhinderung von haarausfall und zur foerderung von haarwuchs |
FR2620330A1 (fr) * | 1987-09-15 | 1989-03-17 | Fabre Pierre Cosmetique | Composition anti-alopecique comportant du minoxidil |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017273A1 (fr) * | 1996-10-25 | 1998-04-30 | Ansan Pharmaceuticals, Inc. | Procedes mettant en oeuvre un acide butyrique ou des derives d'acide butyrique pour prevenir la perte de cheveux |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5037803A (en) | Product comprising a silicon organic compound combined with a cosmetically active substance | |
GB2092445A (en) | Slimming and anti-cellulitic compositions based on plant extracts | |
JP3321712B2 (ja) | マツエキス含有外用養毛剤 | |
KR20120003178A (ko) | 봉독 추출물을 함유하는 피부 미백 및 보습용 조성물 | |
JPH10500126A (ja) | ラミナリン及びラミナリン由来オリゴ糖鎖の化粧品への、並びに、皮膚治療薬調製のための使用 | |
EP0947523A1 (fr) | Dérivés acyl glycosyl d'acide L-ascorbique | |
CA1243957A (fr) | Compose cosmetique et d'hygiene corporelle | |
CN112587593A (zh) | 一种治疗痤疮的组合物及其制备方法 | |
KR100796904B1 (ko) | 안정화된 비타민 c 또는 비타민 c 유도체의 복합체를함유하는 발모제 조성물 | |
ES2140392T5 (es) | Metodo y composicion para mejorar los efectos adversos del envejecimiento. | |
WO1996019187A1 (fr) | Agent stimulant la croissance capillaire | |
ITRM20130657A1 (it) | Trattamento delle dermatopatie mediante estratto vegetale di daphne laureola | |
SU1327791A3 (ru) | Штамм GRIсноSроRоN каSнIWаYама-продуцент вещества,обладающего стимулирующим действием на репаративные процессы кожи, и способ получени вещества, обладающего стимулирующим действием на репаративные процессы кожи | |
GB1603639A (en) | Composition for application to the hair and scalp | |
LU87820A1 (fr) | Utilisation de glycoproteines extraites de bacteries gram(-)pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant | |
AU7224400A (en) | Non-solid composition for local application | |
JP3545057B2 (ja) | 化粧料 | |
RU2010104104A (ru) | Конечные продукты гликирования в качестве действующих веществ | |
CN111686053A (zh) | 具有祛痘、舒缓功能的护肤精华水及其制备方法 | |
JPH03167113A (ja) | 養毛剤 | |
EP0792646A1 (fr) | Compositions cosmétiques ou dermopharmaceutiques contenant un extrait de Solanum lycocarpum | |
RU2144815C1 (ru) | Способ получения регенерирующего косметического крема для ухода за кожей | |
RU2163486C1 (ru) | Средство для лечения псориаза, витилиго и алопеции | |
KR20100120332A (ko) | 식물혼합추출물을 함유하는 발모제 조성물 및 이의 제조방법 | |
RU2148985C1 (ru) | Тонизирующий лосьон для лица |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): RU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |